This timely volume addresses the areas of pathophysiology and
therapy of pulmonary hypertension, which have seen exciting
developments over the past decade. The discoveries of endothelin
overexpression as well as prostacyclin and nitric oxide deficiency
in association with pulmonary hypertension have led to important
therapeutic insights. The new therapies have led to significant
improvements in patient function, quality of life and survival. In
this book, expert authors describe these new therapies. It will be
of interest not only to cardiologists, pulmonary specialists and
rheumatologists, but also many nurses and pharmacotherapists.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!